After The Stock Rose 1.07% Over The Week, Is Marinus Pharmaceuticals Inc (NASDAQ: MRNS) Still A Buy?
Marinus Pharmaceuticals Inc (NASDAQ:MRNS)’s traded shares stood at 0.5 million during the latest session, with the company’s beta value hitting 1.12. At the last check